Vigen Seeds And Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 10-12-2024
- Paid Up Capital ₹ 0.91 M
as on 10-12-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.57 M
as on 10-12-2024
- Satisfied Charges ₹ 2.50 M
as on 10-12-2024
- Revenue 155.03%
(FY 2022)
- Profit 1460.05%
(FY 2022)
- Ebitda 376.90%
(FY 2022)
- Net Worth 29.39%
(FY 2022)
- Total Assets 49.61%
(FY 2022)
About Vigen Seeds And Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 0.91 M.
The company currently has active open charges totaling ₹2.57 M. The company has closed loans amounting to ₹2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ganga Chaurasia, Anita Chaurasia, Manju Chaurasia, and Two other members serve as directors at the Company.
- CIN/LLPIN
U01112UP2005PTC030596
- Company No.
030596
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Sep 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Vigen Seeds And Biotech?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganga Chaurasia  | Director | 01-Sep-2005 | Current |
| Anita Chaurasia | Director | 01-Sep-2005 | Current |
| Manju Chaurasia | Director | 01-Sep-2005 | Current |
| Vinod Dhasmana | Director | 18-Aug-2020 | Current |
| Charan Mehta | Director | 18-Dec-2020 | Current |
Financial Performance of Vigen Seeds And Biotech.
Vigen Seeds And Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 155.03% increase. The company also saw a substantial improvement in profitability, with a 1460.05% increase in profit. The company's net worth Soared by an impressive increase of 29.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vigen Seeds And Biotech?
In 2022, Vigen Seeds And Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 26 Nov 2013 | ₹2.57 M | Open |
Allahabad Bank Creation Date: 31 Mar 2011 | ₹2.50 M | Satisfied |
How Many Employees Work at Vigen Seeds And Biotech?
Unlock and access historical data on people associated with Vigen Seeds And Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vigen Seeds And Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vigen Seeds And Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
